You may not notice any vision changes with background diabetic retinopathy. Treatment isn’t necessary, but improving blood sugar management can help prevent this complication from getting worse. In ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Diabetic retinopathy is a complication of diabetes that affects vision. Nonproliferative diabetic retinopathy describes the earlier stages of the condition before it progresses into the final and most ...

Diabetic retinopathy is a complication of diabetes mellitus that is clinically characterized by changes in retinal microvasculature. Diabetic retinopathy is now better defined as diabetic retinal ...

Diabetic retinopathy (DR) is a leading cause of preventable blindness and has emerged as a global health challenge, necessitating the development of robust management strategies. As DR prevalence ...

Diabetic retinopathy is an eye condition that can cause vision changes and vision loss. There are four stages of diabetic retinopathy based on the findings of a dilated eye exam. Diabetic retinopathy ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

SAN FRANCISCO ― A large observational registry study of almost 100,000 eyes has found that the diabetes drug semaglutide, a GLP-1 agonist recently approved for weight loss, does not worsen the ...

If you have type 1 or type 2 diabetes, you probably already know that you have a greater chance of developing eye problems. One of the most common ones is diabetic retinopathy. This is a condition ...

Not everyone with diabetes will develop diabetic retinopathy. While diabetes-related retinopathy can’t be cured, treatment can slow or stop progression of the disease. If you have early-stage diabetic ...

This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...